Eli Lilly and Company shares (traded on the New York Stock Exchange under the ticker symbol LLY) trade at approximately $1,253.97 per share. Stock valuations shift dynamically throughout active trading hours driven by high demand for its metabolic and diabetes treatments, institutional volume flows, quarterly financial earnings disclosures, and broad biotechnology sector sentiment.